NCT00992316View on ClinicalTrials.gov

To Investigate The Safety, Toleration And Pharmacokinetics Of Single Oral Doses Of PF-04531083 In Healthy Male Subjects

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Pain
Interventions
DRUG

PF-04531083

solution. doses to be selected based upon safety/tolerability/PK at preceeding dose

Trial Locations (1)

1070

Pfizer Investigational Site, Brussels

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY